Figure 5.Molecular docking pose. Utilizing molecular docking to screen potential small compounds for target proteins. Figure shows the OTUB2 active pocket with Trypargine (A), Ormosanine (B), Urothion (C), Piptanthine (D), Sagittatin A (E), Tetrahydropentoxyline (F), Scroside B (G) and Thalirugidine (H) in docking position.
